Metformin and Muscle in Insulin-resistant Older Veterans

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 8, 2014

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Prediabetes
Interventions
DRUG

metformin

Metformin will be given at a dose of 850 mg orally once daily for 1 month with titration up to 850 mg orally twice daily for the remainder of the study.

DRUG

placebo

One placebo capsule by mouth once daily for 1 month followed by one placebo capsule by mouth twice daily for the remainder of the study.

Trial Locations (1)

97239

VA Portland Health Care System, Portland, OR, Portland

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

lead

VA Office of Research and Development

FED

NCT01804049 - Metformin and Muscle in Insulin-resistant Older Veterans | Biotech Hunter | Biotech Hunter